Neuropharmaceutics focuses on the identification of therapeutic targets in nervous system diseases, and then translating those discoveries into drug and therapy development. Neurological disorders have a crucial impact on our society accounting for increased health costs, while drug development to central nervous system (CNS) disorders represents the second investment priority of the pharmaceutical industry, following cancer. Thus, advances in neuropharmaceutics is a key area for students of a PhD programme aiming to target discovery, drug design, medicine development and usage.
The course intends to improve PhD students’ knowledge in the discovery of potential CNS-disease targets leading to the development of new neuroactive drugs, and the improvement of methods to deliver those drugs to the brain, under restricted safety and efficacy requirements.